Faculty Opinions recommendation of The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled study.
2015 ◽
Vol 62
◽
pp. S251-S252
◽
2016 ◽
Vol 65
(4)
◽
pp. 674-682
◽
2008 ◽
Vol 23
(9)
◽
pp. 1320-1326
◽